It has been shown that CRC cells with microsatellite instability (MSI) that have a mutant TGF-β receptor type II are less sensitive to TGF-β–induced EMT than CRC cells with microsatellite stability that have intact TGF-β receptor type II46. Here, TGFB1 is linked to colorectal carcinoma.